当前共找到 23 篇文献分享,本页显示第 21 - 23 篇。
21.
龙海晨 (2025-08-09 19:14):
#paper Korany SM, El-Hendawy HH, Sonbol H, Hamada MA. Partial characterization of levan polymer from Pseudomonas fluorescens with significant cytotoxic and antioxidant activity. Saudi J Biol Sci. 2021 Nov;28(11):6679-6689. doi: 10.1016/j.sjbs.2021.08.008. Epub 2021 Aug 9. PMID: 34764781; PMCID: PMC8568983.这是一篇研究优化微生物产生多糖物质的文章。使用从埃及的土壤中分离出的假单胞菌菌株产生多糖物质(levan),研究发现。蔗糖,二氢磷酸钾,酵母提取物和pH值分别对levan浓度的影响分别显示出显着的影响。纯化的levan聚合物被证明是抗氧化剂和抗癌剂
22.
惊鸿 (2025-08-03 17:32):
#paper Correction of pathogenic mitochondrial DNA in patient-derived disease models using mitochondrial base editors doi:10.1371/journal.pbio.3003207 Published: June 24, 2025 这篇研究展示了线粒体碱基编辑器(DdCBE)在应对线粒体疾病领域的两大关键应用:疾病建模与治疗。令人印象深刻的是,研究者在人类肝类器官中精确引入致病突变(m.15150G>A),成功建立了具有不同异质性水平(即突变DNA占比)的模型,这种精准模拟对研究突变阈值效应和筛选疗法至关重要。更具临床意义的是,该技术在患者来源的成纤维细胞中成功纠正了致病突变(m.4291T>C),恢复了关键的线粒体膜电位,直接在患者细胞层面验证了其功能性治疗的潜力。DdCBE本身表现出高效、特异和持久的编辑效果。迈向应用的关键进展是发现使用mRNA(modRNA)结合脂质纳米颗粒(LNPs)进行递送,相比DNA方法显著提高了编辑效率并大幅降低了细胞毒性。LNPs作为临床验证的非病毒递送系统,为未来体内治疗提供了极具前景的路径。这项工作不仅为理解疾病提供了独特工具,更清晰描绘了基因编辑修复线粒体缺陷、最终造福患者的现实转化路径,尽管体内安全性和递送优化等挑战仍待解决。
Abstract:
Mutations in the mitochondrial genome can cause maternally inherited diseases, cancer, and aging-related conditions. Recent technological progress now enables the creation and correction of mutations in the mitochondrial genome, but … >>>
Mutations in the mitochondrial genome can cause maternally inherited diseases, cancer, and aging-related conditions. Recent technological progress now enables the creation and correction of mutations in the mitochondrial genome, but it remains relatively unknown how patients with primary mitochondrial disease can benefit from this technology. Here, we demonstrate the potential of the double-stranded DNA deaminase toxin A-derived cytosine base editor (DdCBE) to develop disease models and therapeutic strategies for mitochondrial disease in primary human cells. Introduction of the m.15150G > A mutation in liver organoids resulted in organoid lines with varying degrees of heteroplasmy and correspondingly reduced ATP production, providing a unique model to study functional consequences of different levels of heteroplasmy of this mutation. Correction of the m.4291T > C mutation in patient-derived fibroblasts restored mitochondrial membrane potential. DdCBE generated sustainable edits with high specificity and product purity. To prepare for clinical application, we found that mRNA-mediated mitochondrial base editing resulted in increased efficiency and cellular viability compared to DNA-mediated editing. Moreover, we showed efficient delivery of the mRNA mitochondrial base editors using lipid nanoparticles, which is currently the most advanced non-viral in vivo delivery system for gene products. Our study thus demonstrates the potential of mitochondrial base editing to not only generate unique in vitro models to study these diseases, but also to functionally correct mitochondrial mutations in patient-derived cells for future therapeutic purposes. <<<
翻译
23.
少颖-focus reverse aging (2025-08-03 01:07):
#paper DOI: https://doi.org/10.5114/ait/203168 ------------------------------- 杂志:Anaesthesiol Intensive Ther 年份:2025 --------------------------------------- 标题:Anesthesia for robot-assisted surgery: a review ------------------------------------------- 推荐理由:手术机器人能够减轻医生的工作量减少病人的痛苦,这篇文章让我们明白了手术机器人的瓶颈,让我们知道未来如何发展手术机器人技术。 1.生理干扰大 手术依赖充二氧化碳建立气腹和头低脚高体位,会挤压心肺,导致血压波动、呼吸不畅,还可能引发颅内压、眼内压升高,增加脑水肿、视力损伤风险,术后面部颈部水肿也可能影响气道安全。 2.并发症风险高 可能出现气体栓塞(二氧化碳进入血管),导致血压骤降、心跳异常;虽出血量少,但一旦出血更难控制;长时间固定体位还可能压伤神经,引发手脚麻木或无力。 3.操作和空间限制 设备体积大,占用手术室空间,麻醉师难靠近患者,术前需固定好所有管线以防脱落;紧急情况需多步骤卸除机器人,可能延误抢救;手术时间因设备对接、学习曲线长而延长,增加患者低体温风险。 4.患者适用范围窄 严重肥胖、肺病、心脏病、青光眼等患者无法耐受;胸廓过小、有粘连病史的患者,机械臂难以摆放,无法手术。 5.成本高且依赖技术 设备昂贵,仅大型医院能负担;需术者专项培训,且完全依赖人工操作,无自主纠错能力,技术垄断也限制普及。
Abstract:
Robotic surgery has become increasingly popular over the last 30 years. This techniqueis particularly attractive due to its minimally invasive nature, high precision comparedto open and laparoscopic techniques, less postoperative … >>>
Robotic surgery has become increasingly popular over the last 30 years. This techniqueis particularly attractive due to its minimally invasive nature, high precision comparedto open and laparoscopic techniques, less postoperative pain, shorter hospital stay forpatients, and faster recovery. For an anesthesiologist, robot-assisted operations involvenumerous challenges resulting from the surgical technique. The most important problems during anesthesia include changes in physiology resulting from the developmentof pneumoperitoneum and a steep Trendelenburg position. This review discusses problems that may be encountered by an anesthesiologist performing anesthesia duringrobotic surgery. <<<
翻译
回到顶部